While PSD3, CD274, and TNFSF18 were found to be up-regulated in ESCC and associated with immune-related features, only PSD3 demonstrated a significant and paradoxical correlation with patient survival—higher expression predicting better prognosis. This evidence concerns the gene PSD3 and esophageal squamous cell carcinoma.